Are ob patients at risk for MRSA?
The rate of nares colonization with methicillin-resistant Staphylococcus aureus (MRSA) is low in obstetric populations, according to two presentations at this year's annual IDSOG meeting. Although the rate of MRSA colonization is estimated to be 6% to 8% in new hospital admissions, the rate of colonization in obstetric populations was 2% in both studies, performed by Dr. Mara Dinsmoor at Evanston Hospital in Evanston, Ill. and by Dr. Richard Beigi at Cleveland Metro Health Center in Cleveland, Ohio. The study from Illinois reported that over 50% of the colonized mothers had risk factors for MRSA colonization. There was one case of MRSA sepsis in a neonate born to a colonized woman, but the two strains of MRSA were genetically distinct, arguing against vertical transmission from mother to baby.
The rate of nares colonization with methicillin-resistant Staphylococcus aureus (MRSA) is low in obstetric populations, according to two presentations at this year's annual IDSOG meeting. Although the rate of MRSA colonization is estimated to be 6% to 8% in new hospital admissions, the rate of colonization in obstetric populations was 2% in both studies, performed by Dr. Mara Dinsmoor at Evanston Hospital in Evanston, Ill. and by Dr. Richard Beigi at Cleveland Metro Health Center in Cleveland, Ohio. The study from Illinois reported that over 50% of the colonized mothers had risk factors for MRSA colonization. There was one case of MRSA sepsis in a neonate born to a colonized woman, but the two strains of MRSA were genetically distinct, arguing against vertical transmission from mother to baby.
Study links COVID-19 infection to higher low birthweight and preterm birth rates
March 24th 2025A new study found that pregnant women infected with COVID-19, especially in the third trimester or with severe symptoms, faced higher risks of preterm birth, low birthweight, and neonatal intensive care unit admission.
Read More
Expression of mRNA linked to fetal death risk
March 18th 2025A recent study reveals significantly elevated placental interleukin 6 and vascular endothelial growth factor receptor 2 messenger RNA expression in fetal death cases, highlighting inflammation and impaired fetal protection mechanisms.
Read More
